Innovative ETFs Content Hub Healthcare ETFs Lag the Broader Market Amidst Regulation Scare By Max ChenApril 15, 2019
Innovative ETFs Content Hub Healthcare ETFs Deteriorate on Congress’ Threats to Drug Prices By Max ChenApril 12, 2019
Leveraged & Inverse Content Hub Health Care ETFs Get a Boost From Latest Jobs Report By Ben HernandezApril 6, 2019
Innovative ETFs Content Hub Biogen Tanks, Drags Down Biotechnology Sector ETFs By Max ChenMarch 21, 2019
Innovative ETFs Content Hub Healthcare, Biotech ETFs XLV and XBI Slide on FDA’s Uncertain Outlook By Max ChenMarch 6, 2019
Innovative ETFs Content Hub A Specialty Biotech ETF Strengthens on Optimism Over CRISPR Advancements By Max ChenMarch 1, 2019
Innovative ETFs Content Hub Pharmaceutical ETFs Break Out on Horizon Pharma’s Positive Drug Results By Max ChenFebruary 28, 2019
Innovative ETFs Content Hub Specialized Biotech ETF Rallies on MacroGenics Positive Trial Results By Max ChenFebruary 6, 2019
Core Equity Content Hub Healthcare ETFs Slip After Abbot Lab’s Revenue Miss, Weak Outlook By Max ChenJanuary 23, 2019
Equity ETFs Biotech ETFs Pop as Bristol-Myers Squibb Set to Acquire Celgene By Max ChenJanuary 3, 2019
Equity ETFs Healthcare ETFs Looked Pale on Reports J&J Knew About Asbestos in Baby Powder By Max ChenDecember 14, 2018
Equity ETFs ETFs to Help Investors Pick and Choose Their Market Exposures By Max ChenNovember 29, 2018
